Piscataway, NJ, United States of America

Ye Huang

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Shanghai Aucta Pharmaceuticals Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ye Huang. Retrieved from https://idiyas.com/inventor/ye-huang-d1j8ios2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ye Huang - Innovator in Neurological Treatments

Introduction

Ye Huang is a notable inventor based in Piscataway, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for treating neurological and psychiatric conditions. His innovative approach has led to the creation of a unique dosage form that enhances drug delivery and efficacy.

Latest Patents

Ye Huang holds a patent for a formulation of lacosamide. The patent document discloses a dosage form featuring a unique combination of extended-release and immediate-release components of the active ingredient. This innovative dosage form allows for high drug loading, enabling once-daily administration while providing a sustained window of effective treatment with reduced fluctuations in drug concentration. The document also outlines a method for treating neurological or psychiatric diseases or conditions in a subject.

Career Highlights

Ye Huang is associated with Shanghai Aucta Pharmaceuticals Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on patient care and treatment outcomes in the field of neurology.

Collaborations

Some of his coworkers include Fen Ren and Bolun Zhang, who contribute to the collaborative efforts within the company. Their combined expertise enhances the innovative environment at Shanghai Aucta Pharmaceuticals.

Conclusion

Ye Huang's contributions to pharmaceutical formulations represent a significant advancement in the treatment of neurological conditions. His innovative work continues to pave the way for improved therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…